Health insurance startup Bright Health has secured $80 million in Series A funding led by Bessemer Venture Partners and New Enterprise Associates. Flare Capital Partners and others also participated in the funding round. Bright Health will use the funds to support its nationwide rollout. “There’s a better way to better health,” said Bob Sheehy, co-founder and chief executive officer (CEO) of Bright Health. “We are realigning the broken payer-provider relationship, focusing on the consumer and reimagining how technology can simplify the healthcare experience from beginning-to-end. Making that happen and starting a new health plan is no small feat, but we’re confident we have the right team and model to create real and necessary change.”
CrossChx, a healthcare identity solutions provider, has raised a $15 million Series C financing round. Silicon Valley Bank, Khosla Ventures, Drive Capital, NCT Ventures and Moonshots Capital all participated in the financing. CrossChx will use the finds to expand sales and distribution of its flagship product Queue, a patient sign-in system. “Queue finally provides a way for patients to safely log in to healthcare, giving providers the ability to deliver a more personable level of care and returning control of patient identities back to their rightful owners – the patients themselves,” said Sean Lane, Founder and CEO of CrossChx. “Queue signals a new era of patient registration, and this capital will provide the resources to fulfill demand and expand across the country.”
Haptik, a mobile concierge service in India, has secured a Series B round of financing worth $11.2 million, TechCrunch reports. The funding comes from media company Times Internet. Haptik was launched in 2014 and raised $1 million in seed funding that year.
Human Longevity, a genomics-based technology company, has completed a $220 million Series B round of investment. Investors included Illumina, Celgene, GE Ventures and some Series A investors. “The closing of our Series B offering was completed with excellent results for HLI, despite especially challenging external financial markets. This is a tribute to the strength of our science, technology and team. We continue to build our business, develop life changing products and hire world class scientific, clinical and technical leaders to help us meet our goal of revolutionizing healthcare,” said J. Craig Venter, Ph.D., Co-founder and CEO of the company.